epa:iph
|
117299
|
Mar 23rd, 2024 12:00AM
|
Innate Pharma
|
23K
|
201.00
|
Open
|
|
Mar 23rd, 2024 07:21AM
|
Mar 23rd, 2024 07:21AM
|
Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.
Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.
Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.
|
Open
|
biotechnologies, antibodies, immunotherapy, and oncology
|
Open
|
117, Avenue de Luminy
|
Marseille
|
Provence-Alpes-Côte d’Azur
|
FR
|
13009
|
|
Innate Pharma
|
|
|
epa:iph
|
117299
|
Mar 22nd, 2024 12:00AM
|
Innate Pharma
|
23K
|
201.00
|
Open
|
|
Mar 22nd, 2024 07:20AM
|
Mar 22nd, 2024 07:20AM
|
Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.
Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.
Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.
|
Open
|
biotechnologies, antibodies, immunotherapy, and oncology
|
Open
|
117, Avenue de Luminy
|
Marseille
|
Provence-Alpes-Côte d’Azur
|
FR
|
13009
|
|
Innate Pharma
|
|
|
epa:iph
|
117299
|
Mar 20th, 2024 12:00AM
|
Innate Pharma
|
23K
|
200.00
|
Open
|
|
Mar 20th, 2024 08:36AM
|
Mar 20th, 2024 08:36AM
|
Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.
Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.
Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.
|
Open
|
biotechnologies, antibodies, immunotherapy, and oncology
|
Open
|
117, Avenue de Luminy
|
Marseille
|
Provence-Alpes-Côte d’Azur
|
FR
|
13009
|
|
Innate Pharma
|
|
|
epa:iph
|
117299
|
Mar 19th, 2024 12:00AM
|
Innate Pharma
|
23K
|
200.00
|
Open
|
|
Mar 19th, 2024 07:55AM
|
Mar 20th, 2024 04:41AM
|
Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.
Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.
Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.
|
Open
|
biotechnologies, antibodies, immunotherapy, and oncology
|
Open
|
117, Avenue de Luminy
|
Marseille
|
Provence-Alpes-Côte d’Azur
|
FR
|
13009
|
|
Innate Pharma
|
|
|
epa:iph
|
117299
|
Mar 18th, 2024 12:00AM
|
Innate Pharma
|
23K
|
200.00
|
Open
|
|
Mar 18th, 2024 07:32AM
|
Mar 19th, 2024 02:52AM
|
Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.
Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.
Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.
|
Open
|
biotechnologies, antibodies, immunotherapy, and oncology
|
Open
|
117, Avenue de Luminy
|
Marseille
|
Provence-Alpes-Côte d’Azur
|
FR
|
13009
|
|
Innate Pharma
|
|
|
epa:iph
|
117299
|
Mar 17th, 2024 12:00AM
|
Innate Pharma
|
23K
|
200.00
|
Open
|
|
Mar 18th, 2024 02:03AM
|
Mar 18th, 2024 02:03AM
|
Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.
Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.
Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.
|
Open
|
biotechnologies, antibodies, immunotherapy, and oncology
|
Open
|
117, Avenue de Luminy
|
Marseille
|
Provence-Alpes-Côte d’Azur
|
FR
|
13009
|
|
Innate Pharma
|
|
|
epa:iph
|
117299
|
Mar 16th, 2024 12:00AM
|
Innate Pharma
|
23K
|
200.00
|
Open
|
|
Mar 16th, 2024 06:54AM
|
Mar 16th, 2024 06:54AM
|
Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.
Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.
Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.
|
Open
|
biotechnologies, antibodies, immunotherapy, and oncology
|
Open
|
117, Avenue de Luminy
|
Marseille
|
Provence-Alpes-Côte d’Azur
|
FR
|
13009
|
|
Innate Pharma
|
|
|
epa:iph
|
117299
|
Mar 15th, 2024 12:00AM
|
Innate Pharma
|
23K
|
200.00
|
Open
|
|
Mar 15th, 2024 01:24PM
|
Mar 15th, 2024 03:09PM
|
Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.
Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.
Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.
|
Open
|
biotechnologies, antibodies, immunotherapy, and oncology
|
Open
|
117, Avenue de Luminy
|
Marseille
|
Provence-Alpes-Côte d’Azur
|
FR
|
13009
|
|
Innate Pharma
|
|
|
epa:iph
|
117299
|
Mar 14th, 2024 12:00AM
|
Innate Pharma
|
23K
|
200.00
|
Open
|
|
Mar 14th, 2024 07:51AM
|
Mar 14th, 2024 06:34PM
|
Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.
Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.
Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.
|
Open
|
biotechnologies, antibodies, immunotherapy, and oncology
|
Open
|
117, Avenue de Luminy
|
Marseille
|
Provence-Alpes-Côte d’Azur
|
FR
|
13009
|
|
Innate Pharma
|
|
|
epa:iph
|
117299
|
Mar 13th, 2024 12:00AM
|
Innate Pharma
|
23K
|
200.00
|
Open
|
|
Mar 13th, 2024 05:53AM
|
Mar 13th, 2024 05:00PM
|
Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.
Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.
Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.
|
Open
|
biotechnologies, antibodies, immunotherapy, and oncology
|
Open
|
117, Avenue de Luminy
|
Marseille
|
Provence-Alpes-Côte d’Azur
|
FR
|
13009
|
|
Innate Pharma
|
|
|